comparison of glp 1 drugs Rx Trends: Real-World Data on GLP-1s for Weight Loss developed bundle cultivating targeted restoration across the Gut What are the side effects

Due to their preclinical testing and lack of comparison with other dual receptor agonists such as tirzepatide, further studies are needed to determine whether the effects of these unimolecular compounds are superior to those of clinically tested drugs

Commonly reported issues include: Gastrointestinal Distress: Nausea, vomiting, and diarrhea are common, particularly when starting the medication

Extracellular fluid volume expansion uncovers a natriuretic action of GLP-1: A functional GLP-1-renal axis in man

There are several different GLP-1 receptor agonists approved for the treatment of Type 2 diabetes

10.1016/j.cmet.2020.05.001 65 VasuP.DorairajE

The EMA recommended adding NAION to the product information (similar to the drugs warning label)